EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The diverse roles of sphingolipids in inflammatory bowel disease

Chelsea L Doll iD, Ashley J Snider iD

The FASEB Journal · 15.07.2024 · 38 (13)

DOI: 10.1096/fj.202400830r ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 27.06.2024. Verfasst von Chelsea L Doll und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Nutritional Sciences and Wellness, University of Arizona, Tucson, Arizona, USA. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Sphingolipids. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of inflammatory bowel disease (IBD) has increased over the last 20 years. A variety of causes, both physiological and environmental, contribute to the initiation and progression of IBD, making disease management challenging. Current treatment options target various aspects of the immune response to dampen intestinal inflammation; however, their effectiveness at retaining remission, their side effects, and loss of response from patients over time warrant further investigation. Finding a common thread within the multitude causes of IBD is critical in developing robust treatment options. Sphingolipids are evolutionary conserved bioactive lipids universally generated in all cell types. This diverse lipid family is involved in a variety of fundamental, yet sometimes opposing, processes such as proliferation and apoptosis. Implicated as regulators in intestinal diseases, sphingolipids are a potential cornerstone in understanding IBD. Herein we will describe the role of host‐ and microbial‐derived sphingolipids as they relate to the many factors of intestinal health and IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesSphingolipidsHumansAnimals

Stichwörter der Autor:innen

Crohn's diseaseceramidecolitiscolitis‐associated cancercolorectal cancerinflammationinflammatory bowel diseasemicrobiomesphingolipidssphingosine‐1‐phosphate

Substanzen

Sphingolipids

Autor:innen und Institutionen

  • School of Nutritional Sciences and Wellness, University of Arizona, Tucson, Arizona, USA.
  • University of Arizona Cancer Center, University of Arizona, Tucson, Arizona, USA.

ORCID-Profile: Chelsea L Doll, Ashley J Snider

Förderung

  • NIDDK NIH HHS
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Doll, C. L., & Snider, A. J. (2024). The diverse roles of sphingolipids in inflammatory bowel disease. The FASEB Journal, 38(13). https://doi.org/10.1096/fj.202400830r

Vancouver

Doll CL, Snider AJ. The diverse roles of sphingolipids in inflammatory bowel disease. The FASEB Journal. 2024;38(13). doi:10.1096/fj.202400830r

BibTeX
@article{Doll2024,
  author = {Doll, Chelsea L and Snider, Ashley J},
  title = {The diverse roles of sphingolipids in inflammatory bowel disease},
  journal = {The FASEB Journal},
  year = {2024},
  volume = {38},
  number = {13},
  doi = {10.1096/fj.202400830r}
}
Kostenlos starten →